European multicenter study on antimicrobial resistance in bacteria isolated from companion animal urinary tract infections

Table 8 Temporal trends of antimicrobial resistance in Proteus spp. by country

Country^a (Years)	AMC	FLU	SXT
Country^a (Years)	OR^b (95 % CI)^c P value	OR^b (95 % CI) ^c P value	OR^b (95 % CI) ^c P value
BE (2010–13)	0.627 (0.312–1.259) 0.1889	1.292 (1.006–1.659) 0.0450	0.891 (0.726–1.092) 0.2649
FR (2010–13)	0.945 (0.625–1.431) 0.7908	1.004 (0.764–1.319) 0.9770	0.954 (0.756–1.205) 0.6944
NL (2008–13)	1.092 (0.860–1.387) 0.4709	0.970 (0.829–1.135) 0.7067	1.010 (0.903–1.129) 0.8660
SE (2008–13)	0.892 (0.657–1.210) 0.4620	0.884 (0.494–1.583) 0.6788	0.941 (0.759–1.165) 0.5756

AMC amoxicillin clavulanate, FLU fluoroquinolones, SXT trimethoprim/sulfamethoxazole
Statistically significant trends are highlighted in bold
^aBE, Belgium; DK, Denmark; FR, France; NL, the Netherlands; SE, Sweden; CH, Switzerland
^bOR, Odds ratio
^c95 % CI, 95 % Confidence interval

ISSN: 1746-6148